nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP1A2—type 2 diabetes mellitus	0.136	0.602	CbGaD
Amiodarone—CYP3A4—type 2 diabetes mellitus	0.0898	0.398	CbGaD
Amiodarone—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0242	0.0488	CbGbCtD
Amiodarone—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0223	0.0449	CbGbCtD
Amiodarone—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0179	0.0361	CbGbCtD
Amiodarone—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0143	0.0288	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0136	0.0274	CbGbCtD
Amiodarone—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0136	0.0274	CbGbCtD
Amiodarone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0136	0.0274	CbGbCtD
Amiodarone—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0129	0.0261	CbGbCtD
Amiodarone—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0128	0.0257	CbGbCtD
Amiodarone—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0125	0.0252	CbGbCtD
Amiodarone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0121	0.0244	CbGbCtD
Amiodarone—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0119	0.0241	CbGbCtD
Amiodarone—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0115	0.0232	CbGbCtD
Amiodarone—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0114	0.023	CbGbCtD
Amiodarone—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0108	0.0219	CbGbCtD
Amiodarone—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0108	0.0219	CbGbCtD
Amiodarone—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0106	0.0214	CbGbCtD
Amiodarone—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0102	0.0205	CbGbCtD
Amiodarone—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.01	0.0202	CbGbCtD
Amiodarone—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00967	0.0195	CbGbCtD
Amiodarone—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0094	0.0189	CbGbCtD
Amiodarone—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00924	0.0186	CbGbCtD
Amiodarone—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00902	0.0182	CbGbCtD
Amiodarone—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00902	0.0182	CbGbCtD
Amiodarone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00875	0.0176	CbGbCtD
Amiodarone—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00832	0.0168	CbGbCtD
Amiodarone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00825	0.0166	CbGbCtD
Amiodarone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00814	0.0164	CbGbCtD
Amiodarone—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00804	0.0162	CbGbCtD
Amiodarone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00761	0.0153	CbGbCtD
Amiodarone—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00735	0.0148	CbGbCtD
Amiodarone—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00727	0.0147	CbGbCtD
Amiodarone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00725	0.0146	CbGbCtD
Amiodarone—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00688	0.0139	CbGbCtD
Amiodarone—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00684	0.0138	CbGbCtD
Amiodarone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00663	0.0134	CbGbCtD
Amiodarone—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00655	0.0132	CbGbCtD
Amiodarone—CYP3A5—Losartan—type 2 diabetes mellitus	0.0063	0.0127	CbGbCtD
Amiodarone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00625	0.0126	CbGbCtD
Amiodarone—CYP2C8—Losartan—type 2 diabetes mellitus	0.00605	0.0122	CbGbCtD
Amiodarone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00601	0.0121	CbGbCtD
Amiodarone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00599	0.0121	CbGbCtD
Amiodarone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0058	0.0117	CbGbCtD
Amiodarone—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00555	0.0112	CbGbCtD
Amiodarone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00524	0.0106	CbGbCtD
Amiodarone—CYP2C19—Losartan—type 2 diabetes mellitus	0.00508	0.0102	CbGbCtD
Amiodarone—CYP1A2—Losartan—type 2 diabetes mellitus	0.00469	0.00945	CbGbCtD
Amiodarone—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00462	0.00931	CbGbCtD
Amiodarone—ABCB1—Glyburide—type 2 diabetes mellitus	0.00448	0.00903	CbGbCtD
Amiodarone—CYP2C9—Losartan—type 2 diabetes mellitus	0.00422	0.00851	CbGbCtD
Amiodarone—ABCB1—Losartan—type 2 diabetes mellitus	0.0041	0.00826	CbGbCtD
Amiodarone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00397	0.00801	CbGbCtD
Amiodarone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00381	0.00768	CbGbCtD
Amiodarone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00381	0.00768	CbGbCtD
Amiodarone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0036	0.00726	CbGbCtD
Amiodarone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00268	0.00541	CbGbCtD
Amiodarone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00246	0.00495	CbGbCtD
Amiodarone—Cinchocaine—CALM1—type 2 diabetes mellitus	0.00119	0.579	CrCbGaD
Amiodarone—EBP—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00107	1	CbGdCrCtD
Amiodarone—CACNA2D2—islet of Langerhans—type 2 diabetes mellitus	0.000913	0.0571	CbGeAlD
Amiodarone—EBP—liver—type 2 diabetes mellitus	0.000701	0.0438	CbGeAlD
Amiodarone—THRA—cardiovascular system—type 2 diabetes mellitus	0.000668	0.0417	CbGeAlD
Amiodarone—THRB—kidney—type 2 diabetes mellitus	0.000653	0.0408	CbGeAlD
Amiodarone—THRA—kidney—type 2 diabetes mellitus	0.000653	0.0408	CbGeAlD
Amiodarone—THRB—adipose tissue—type 2 diabetes mellitus	0.000589	0.0368	CbGeAlD
Amiodarone—THRA—adipose tissue—type 2 diabetes mellitus	0.000589	0.0368	CbGeAlD
Amiodarone—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.00054	0.0338	CbGeAlD
Amiodarone—CACNA1H—cardiovascular system—type 2 diabetes mellitus	0.000536	0.0335	CbGeAlD
Amiodarone—Dronedarone—ADRA2A—type 2 diabetes mellitus	0.000465	0.226	CrCbGaD
Amiodarone—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000462	0.0289	CbGeAlD
Amiodarone—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.000423	0.0264	CbGeAlD
Amiodarone—THRB—liver—type 2 diabetes mellitus	0.000413	0.0258	CbGeAlD
Amiodarone—THRA—liver—type 2 diabetes mellitus	0.000413	0.0258	CbGeAlD
Amiodarone—CYP3A7—liver—type 2 diabetes mellitus	0.000353	0.0221	CbGeAlD
Amiodarone—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.00035	0.0219	CbGeAlD
Amiodarone—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.00034	0.0213	CbGeAlD
Amiodarone—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000336	0.021	CbGeAlD
Amiodarone—CACNA1H—liver—type 2 diabetes mellitus	0.000331	0.0207	CbGeAlD
Amiodarone—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000319	0.0199	CbGeAlD
Amiodarone—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.0003	0.0188	CbGeAlD
Amiodarone—SIGMAR1—pancreas—type 2 diabetes mellitus	0.000297	0.0186	CbGeAlD
Amiodarone—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.000291	0.0182	CbGeAlD
Amiodarone—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000281	0.0176	CbGeAlD
Amiodarone—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000278	0.0174	CbGeAlD
Amiodarone—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000269	0.0168	CbGeAlD
Amiodarone—CYP2A6—liver—type 2 diabetes mellitus	0.000245	0.0153	CbGeAlD
Amiodarone—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000243	0.0152	CbGeAlD
Amiodarone—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000224	0.014	CbGeAlD
Amiodarone—CYP2C8—kidney—type 2 diabetes mellitus	0.000218	0.0136	CbGeAlD
Amiodarone—Dronedarone—CYP3A4—type 2 diabetes mellitus	0.000214	0.104	CrCbGaD
Amiodarone—CYP1A1—kidney—type 2 diabetes mellitus	0.000201	0.0126	CbGeAlD
Amiodarone—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000198	0.0124	CbGeAlD
Amiodarone—CYP3A5—kidney—type 2 diabetes mellitus	0.000197	0.0123	CbGeAlD
Amiodarone—CYP3A5—pancreas—type 2 diabetes mellitus	0.000195	0.0122	CbGeAlD
Amiodarone—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000191	0.012	CbGeAlD
Amiodarone—SIGMAR1—liver—type 2 diabetes mellitus	0.000189	0.0118	CbGeAlD
Amiodarone—Dronedarone—ALB—type 2 diabetes mellitus	0.000187	0.0907	CrCbGaD
Amiodarone—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000181	0.0113	CbGeAlD
Amiodarone—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000177	0.0111	CbGeAlD
Amiodarone—CYP2C19—liver—type 2 diabetes mellitus	0.000158	0.00986	CbGeAlD
Amiodarone—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000148	0.00922	CbGeAlD
Amiodarone—CYP3A4—kidney—type 2 diabetes mellitus	0.000147	0.00922	CbGeAlD
Amiodarone—CYP2D6—kidney—type 2 diabetes mellitus	0.000145	0.00907	CbGeAlD
Amiodarone—CYP2C8—liver—type 2 diabetes mellitus	0.000138	0.0086	CbGeAlD
Amiodarone—CYP1A2—liver—type 2 diabetes mellitus	0.000129	0.00805	CbGeAlD
Amiodarone—CYP1A1—liver—type 2 diabetes mellitus	0.000127	0.00794	CbGeAlD
Amiodarone—ABCB1—retina—type 2 diabetes mellitus	0.000126	0.00788	CbGeAlD
Amiodarone—CYP3A5—liver—type 2 diabetes mellitus	0.000124	0.00776	CbGeAlD
Amiodarone—CYP2C9—liver—type 2 diabetes mellitus	0.000122	0.00764	CbGeAlD
Amiodarone—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000119	0.00743	CbGeAlD
Amiodarone—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000107	0.00667	CbGeAlD
Amiodarone—ABCB1—kidney—type 2 diabetes mellitus	0.000104	0.00653	CbGeAlD
Amiodarone—ABCB1—pancreas—type 2 diabetes mellitus	0.000104	0.00648	CbGeAlD
Amiodarone—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000102	0.00636	CbGeAlD
Amiodarone—ABCB1—adipose tissue—type 2 diabetes mellitus	9.41e-05	0.00588	CbGeAlD
Amiodarone—CYP3A4—liver—type 2 diabetes mellitus	9.32e-05	0.00583	CbGeAlD
Amiodarone—CYP2D6—liver—type 2 diabetes mellitus	9.17e-05	0.00573	CbGeAlD
Amiodarone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	6.94e-05	0.000414	CcSEcCtD
Amiodarone—Discomfort—Metformin—type 2 diabetes mellitus	6.93e-05	0.000413	CcSEcCtD
Amiodarone—Fatigue—Gliclazide—type 2 diabetes mellitus	6.93e-05	0.000413	CcSEcCtD
Amiodarone—Nausea—Glipizide—type 2 diabetes mellitus	6.91e-05	0.000412	CcSEcCtD
Amiodarone—Vomiting—Glimepiride—type 2 diabetes mellitus	6.9e-05	0.000411	CcSEcCtD
Amiodarone—Hypotension—Valsartan—type 2 diabetes mellitus	6.9e-05	0.000411	CcSEcCtD
Amiodarone—Vision blurred—Losartan—type 2 diabetes mellitus	6.9e-05	0.000411	CcSEcCtD
Amiodarone—Vomiting—Sitagliptin—type 2 diabetes mellitus	6.88e-05	0.00041	CcSEcCtD
Amiodarone—Constipation—Gliclazide—type 2 diabetes mellitus	6.87e-05	0.00041	CcSEcCtD
Amiodarone—Pain—Gliclazide—type 2 diabetes mellitus	6.87e-05	0.00041	CcSEcCtD
Amiodarone—Tremor—Losartan—type 2 diabetes mellitus	6.86e-05	0.000409	CcSEcCtD
Amiodarone—Rash—Glimepiride—type 2 diabetes mellitus	6.84e-05	0.000408	CcSEcCtD
Amiodarone—Dermatitis—Glimepiride—type 2 diabetes mellitus	6.84e-05	0.000407	CcSEcCtD
Amiodarone—Rash—Sitagliptin—type 2 diabetes mellitus	6.82e-05	0.000407	CcSEcCtD
Amiodarone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	6.81e-05	0.000406	CcSEcCtD
Amiodarone—Erythema multiforme—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000406	CcSEcCtD
Amiodarone—Headache—Glimepiride—type 2 diabetes mellitus	6.8e-05	0.000405	CcSEcCtD
Amiodarone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	6.79e-05	0.000405	CcSEcCtD
Amiodarone—Cough—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000404	CcSEcCtD
Amiodarone—Headache—Sitagliptin—type 2 diabetes mellitus	6.78e-05	0.000404	CcSEcCtD
Amiodarone—Agitation—Losartan—type 2 diabetes mellitus	6.72e-05	0.000401	CcSEcCtD
Amiodarone—Oedema—Metformin—type 2 diabetes mellitus	6.72e-05	0.000401	CcSEcCtD
Amiodarone—Tinnitus—Ramipril—type 2 diabetes mellitus	6.72e-05	0.0004	CcSEcCtD
Amiodarone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.7e-05	0.000399	CcSEcCtD
Amiodarone—Flushing—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000399	CcSEcCtD
Amiodarone—Angioedema—Losartan—type 2 diabetes mellitus	6.69e-05	0.000398	CcSEcCtD
Amiodarone—Infection—Metformin—type 2 diabetes mellitus	6.68e-05	0.000398	CcSEcCtD
Amiodarone—Insomnia—Valsartan—type 2 diabetes mellitus	6.68e-05	0.000398	CcSEcCtD
Amiodarone—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.63e-05	0.000395	CcSEcCtD
Amiodarone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.62e-05	0.000395	CcSEcCtD
Amiodarone—Shock—Metformin—type 2 diabetes mellitus	6.62e-05	0.000394	CcSEcCtD
Amiodarone—Insomnia—Orlistat—type 2 diabetes mellitus	6.6e-05	0.000393	CcSEcCtD
Amiodarone—ABCB1—liver—type 2 diabetes mellitus	6.6e-05	0.00412	CbGeAlD
Amiodarone—Malaise—Losartan—type 2 diabetes mellitus	6.6e-05	0.000393	CcSEcCtD
Amiodarone—Anxiety—Irbesartan—type 2 diabetes mellitus	6.6e-05	0.000393	CcSEcCtD
Amiodarone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.59e-05	0.000393	CcSEcCtD
Amiodarone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.58e-05	0.000392	CcSEcCtD
Amiodarone—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.58e-05	0.000392	CcSEcCtD
Amiodarone—Vertigo—Losartan—type 2 diabetes mellitus	6.57e-05	0.000392	CcSEcCtD
Amiodarone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.57e-05	0.000392	CcSEcCtD
Amiodarone—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.55e-05	0.00039	CcSEcCtD
Amiodarone—Discomfort—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.00039	CcSEcCtD
Amiodarone—Skin disorder—Metformin—type 2 diabetes mellitus	6.53e-05	0.000389	CcSEcCtD
Amiodarone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.5e-05	0.000387	CcSEcCtD
Amiodarone—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.5e-05	0.000387	CcSEcCtD
Amiodarone—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.47e-05	0.000386	CcSEcCtD
Amiodarone—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.47e-05	0.000386	CcSEcCtD
Amiodarone—Nausea—Glimepiride—type 2 diabetes mellitus	6.45e-05	0.000384	CcSEcCtD
Amiodarone—Arrhythmia—Ramipril—type 2 diabetes mellitus	6.44e-05	0.000384	CcSEcCtD
Amiodarone—Nausea—Sitagliptin—type 2 diabetes mellitus	6.43e-05	0.000383	CcSEcCtD
Amiodarone—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.42e-05	0.000383	CcSEcCtD
Amiodarone—Asthenia—Glyburide—type 2 diabetes mellitus	6.42e-05	0.000383	CcSEcCtD
Amiodarone—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.42e-05	0.000383	CcSEcCtD
Amiodarone—Anorexia—Metformin—type 2 diabetes mellitus	6.41e-05	0.000382	CcSEcCtD
Amiodarone—Cough—Losartan—type 2 diabetes mellitus	6.38e-05	0.000381	CcSEcCtD
Amiodarone—Urticaria—Gliclazide—type 2 diabetes mellitus	6.38e-05	0.000381	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.37e-05	0.00038	CcSEcCtD
Amiodarone—Alopecia—Ramipril—type 2 diabetes mellitus	6.37e-05	0.00038	CcSEcCtD
Amiodarone—Fatigue—Valsartan—type 2 diabetes mellitus	6.37e-05	0.000379	CcSEcCtD
Amiodarone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.35e-05	0.000379	CcSEcCtD
Amiodarone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.35e-05	0.000379	CcSEcCtD
Amiodarone—Oedema—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.000378	CcSEcCtD
Amiodarone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.000378	CcSEcCtD
Amiodarone—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.34e-05	0.000378	CcSEcCtD
Amiodarone—Pruritus—Glyburide—type 2 diabetes mellitus	6.33e-05	0.000377	CcSEcCtD
Amiodarone—Constipation—Valsartan—type 2 diabetes mellitus	6.31e-05	0.000376	CcSEcCtD
Amiodarone—Infection—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000376	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.3e-05	0.000375	CcSEcCtD
Amiodarone—Fatigue—Orlistat—type 2 diabetes mellitus	6.29e-05	0.000375	CcSEcCtD
Amiodarone—Hypotension—Metformin—type 2 diabetes mellitus	6.28e-05	0.000374	CcSEcCtD
Amiodarone—Erythema—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000374	CcSEcCtD
Amiodarone—Shock—Irbesartan—type 2 diabetes mellitus	6.24e-05	0.000372	CcSEcCtD
Amiodarone—Pain—Orlistat—type 2 diabetes mellitus	6.24e-05	0.000372	CcSEcCtD
Amiodarone—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.22e-05	0.000371	CcSEcCtD
Amiodarone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.00037	CcSEcCtD
Amiodarone—Anxiety—Losartan—type 2 diabetes mellitus	6.21e-05	0.00037	CcSEcCtD
Amiodarone—Tachycardia—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000369	CcSEcCtD
Amiodarone—Rash—Bromocriptine—type 2 diabetes mellitus	6.17e-05	0.000368	CcSEcCtD
Amiodarone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.17e-05	0.000368	CcSEcCtD
Amiodarone—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.16e-05	0.000367	CcSEcCtD
Amiodarone—Discomfort—Losartan—type 2 diabetes mellitus	6.15e-05	0.000367	CcSEcCtD
Amiodarone—Dysgeusia—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000366	CcSEcCtD
Amiodarone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.13e-05	0.000366	CcSEcCtD
Amiodarone—Headache—Bromocriptine—type 2 diabetes mellitus	6.13e-05	0.000366	CcSEcCtD
Amiodarone—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.12e-05	0.000365	CcSEcCtD
Amiodarone—Dry mouth—Losartan—type 2 diabetes mellitus	6.09e-05	0.000363	CcSEcCtD
Amiodarone—Anorexia—Irbesartan—type 2 diabetes mellitus	6.05e-05	0.00036	CcSEcCtD
Amiodarone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.04e-05	0.00036	CcSEcCtD
Amiodarone—Paraesthesia—Metformin—type 2 diabetes mellitus	6.04e-05	0.00036	CcSEcCtD
Amiodarone—Confusional state—Losartan—type 2 diabetes mellitus	6.02e-05	0.000359	CcSEcCtD
Amiodarone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.01e-05	0.000358	CcSEcCtD
Amiodarone—Dyspnoea—Metformin—type 2 diabetes mellitus	5.99e-05	0.000357	CcSEcCtD
Amiodarone—Oedema—Losartan—type 2 diabetes mellitus	5.97e-05	0.000356	CcSEcCtD
Amiodarone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.97e-05	0.000356	CcSEcCtD
Amiodarone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.97e-05	0.000356	CcSEcCtD
Amiodarone—Infection—Losartan—type 2 diabetes mellitus	5.93e-05	0.000354	CcSEcCtD
Amiodarone—Hypotension—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.000353	CcSEcCtD
Amiodarone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.92e-05	0.000353	CcSEcCtD
Amiodarone—Dyspepsia—Metformin—type 2 diabetes mellitus	5.92e-05	0.000353	CcSEcCtD
Amiodarone—Tremor—Ramipril—type 2 diabetes mellitus	5.88e-05	0.00035	CcSEcCtD
Amiodarone—Shock—Losartan—type 2 diabetes mellitus	5.88e-05	0.00035	CcSEcCtD
Amiodarone—Urticaria—Valsartan—type 2 diabetes mellitus	5.87e-05	0.00035	CcSEcCtD
Amiodarone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.85e-05	0.000348	CcSEcCtD
Amiodarone—Decreased appetite—Metformin—type 2 diabetes mellitus	5.85e-05	0.000348	CcSEcCtD
Amiodarone—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.84e-05	0.000348	CcSEcCtD
Amiodarone—Tachycardia—Losartan—type 2 diabetes mellitus	5.83e-05	0.000347	CcSEcCtD
Amiodarone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000347	CcSEcCtD
Amiodarone—Nausea—Bromocriptine—type 2 diabetes mellitus	5.82e-05	0.000347	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.81e-05	0.000346	CcSEcCtD
Amiodarone—Fatigue—Metformin—type 2 diabetes mellitus	5.8e-05	0.000345	CcSEcCtD
Amiodarone—Urticaria—Orlistat—type 2 diabetes mellitus	5.8e-05	0.000345	CcSEcCtD
Amiodarone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.77e-05	0.000344	CcSEcCtD
Amiodarone—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.77e-05	0.000344	CcSEcCtD
Amiodarone—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.77e-05	0.000344	CcSEcCtD
Amiodarone—Asthenia—Gliclazide—type 2 diabetes mellitus	5.77e-05	0.000344	CcSEcCtD
Amiodarone—Agitation—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000344	CcSEcCtD
Amiodarone—Constipation—Metformin—type 2 diabetes mellitus	5.75e-05	0.000343	CcSEcCtD
Amiodarone—Angioedema—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000342	CcSEcCtD
Amiodarone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.7e-05	0.00034	CcSEcCtD
Amiodarone—Anorexia—Losartan—type 2 diabetes mellitus	5.69e-05	0.000339	CcSEcCtD
Amiodarone—Vomiting—Glyburide—type 2 diabetes mellitus	5.69e-05	0.000339	CcSEcCtD
Amiodarone—Pruritus—Gliclazide—type 2 diabetes mellitus	5.69e-05	0.000339	CcSEcCtD
Amiodarone—Malaise—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000337	CcSEcCtD
Amiodarone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.66e-05	0.000337	CcSEcCtD
Amiodarone—Rash—Glyburide—type 2 diabetes mellitus	5.64e-05	0.000336	CcSEcCtD
Amiodarone—Dermatitis—Glyburide—type 2 diabetes mellitus	5.64e-05	0.000336	CcSEcCtD
Amiodarone—Vertigo—Ramipril—type 2 diabetes mellitus	5.64e-05	0.000336	CcSEcCtD
Amiodarone—Headache—Glyburide—type 2 diabetes mellitus	5.61e-05	0.000334	CcSEcCtD
Amiodarone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.59e-05	0.000333	CcSEcCtD
Amiodarone—Hypotension—Losartan—type 2 diabetes mellitus	5.58e-05	0.000333	CcSEcCtD
Amiodarone—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.54e-05	0.00033	CcSEcCtD
Amiodarone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.52e-05	0.000329	CcSEcCtD
Amiodarone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.5e-05	0.000328	CcSEcCtD
Amiodarone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.5e-05	0.000328	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.48e-05	0.000326	CcSEcCtD
Amiodarone—Cough—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000326	CcSEcCtD
Amiodarone—Fatigue—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000326	CcSEcCtD
Amiodarone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.44e-05	0.000324	CcSEcCtD
Amiodarone—Pain—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000323	CcSEcCtD
Amiodarone—Constipation—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000323	CcSEcCtD
Amiodarone—Insomnia—Losartan—type 2 diabetes mellitus	5.4e-05	0.000322	CcSEcCtD
Amiodarone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.38e-05	0.00032	CcSEcCtD
Amiodarone—Paraesthesia—Losartan—type 2 diabetes mellitus	5.36e-05	0.00032	CcSEcCtD
Amiodarone—Urticaria—Metformin—type 2 diabetes mellitus	5.34e-05	0.000318	CcSEcCtD
Amiodarone—Dyspnoea—Losartan—type 2 diabetes mellitus	5.32e-05	0.000317	CcSEcCtD
Amiodarone—Anxiety—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000317	CcSEcCtD
Amiodarone—Nausea—Glyburide—type 2 diabetes mellitus	5.32e-05	0.000317	CcSEcCtD
Amiodarone—Abdominal pain—Metformin—type 2 diabetes mellitus	5.32e-05	0.000317	CcSEcCtD
Amiodarone—Dizziness—Gliclazide—type 2 diabetes mellitus	5.31e-05	0.000317	CcSEcCtD
Amiodarone—Asthenia—Valsartan—type 2 diabetes mellitus	5.3e-05	0.000316	CcSEcCtD
Amiodarone—Discomfort—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000315	CcSEcCtD
Amiodarone—Dyspepsia—Losartan—type 2 diabetes mellitus	5.26e-05	0.000313	CcSEcCtD
Amiodarone—Asthenia—Orlistat—type 2 diabetes mellitus	5.23e-05	0.000312	CcSEcCtD
Amiodarone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000312	CcSEcCtD
Amiodarone—Pruritus—Valsartan—type 2 diabetes mellitus	5.22e-05	0.000311	CcSEcCtD
Amiodarone—Dry mouth—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000311	CcSEcCtD
Amiodarone—Decreased appetite—Losartan—type 2 diabetes mellitus	5.19e-05	0.000309	CcSEcCtD
Amiodarone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.19e-05	0.000309	CcSEcCtD
Amiodarone—Confusional state—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000308	CcSEcCtD
Amiodarone—Pruritus—Orlistat—type 2 diabetes mellitus	5.16e-05	0.000308	CcSEcCtD
Amiodarone—Fatigue—Losartan—type 2 diabetes mellitus	5.15e-05	0.000307	CcSEcCtD
Amiodarone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000305	CcSEcCtD
Amiodarone—Oedema—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000305	CcSEcCtD
Amiodarone—Vomiting—Gliclazide—type 2 diabetes mellitus	5.11e-05	0.000305	CcSEcCtD
Amiodarone—Pain—Losartan—type 2 diabetes mellitus	5.11e-05	0.000304	CcSEcCtD
Amiodarone—Constipation—Losartan—type 2 diabetes mellitus	5.11e-05	0.000304	CcSEcCtD
Amiodarone—Rash—Gliclazide—type 2 diabetes mellitus	5.07e-05	0.000302	CcSEcCtD
Amiodarone—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.06e-05	0.000302	CcSEcCtD
Amiodarone—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.05e-05	0.000301	CcSEcCtD
Amiodarone—Urticaria—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.0003	CcSEcCtD
Amiodarone—Shock—Ramipril—type 2 diabetes mellitus	5.04e-05	0.0003	CcSEcCtD
Amiodarone—Headache—Gliclazide—type 2 diabetes mellitus	5.03e-05	0.0003	CcSEcCtD
Amiodarone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000299	CcSEcCtD
Amiodarone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000299	CcSEcCtD
Amiodarone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000299	CcSEcCtD
Amiodarone—Tachycardia—Ramipril—type 2 diabetes mellitus	5e-05	0.000298	CcSEcCtD
Amiodarone—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.99e-05	0.000298	CcSEcCtD
Amiodarone—Skin disorder—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000296	CcSEcCtD
Amiodarone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000295	CcSEcCtD
Amiodarone—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.92e-05	0.000293	CcSEcCtD
Amiodarone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.88e-05	0.000291	CcSEcCtD
Amiodarone—Dizziness—Valsartan—type 2 diabetes mellitus	4.88e-05	0.000291	CcSEcCtD
Amiodarone—Anorexia—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000291	CcSEcCtD
Amiodarone—Dizziness—Orlistat—type 2 diabetes mellitus	4.82e-05	0.000288	CcSEcCtD
Amiodarone—Asthenia—Metformin—type 2 diabetes mellitus	4.82e-05	0.000288	CcSEcCtD
Amiodarone—Hypotension—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000285	CcSEcCtD
Amiodarone—Nausea—Gliclazide—type 2 diabetes mellitus	4.77e-05	0.000285	CcSEcCtD
Amiodarone—Pruritus—Metformin—type 2 diabetes mellitus	4.76e-05	0.000284	CcSEcCtD
Amiodarone—Urticaria—Losartan—type 2 diabetes mellitus	4.74e-05	0.000283	CcSEcCtD
Amiodarone—Abdominal pain—Losartan—type 2 diabetes mellitus	4.72e-05	0.000281	CcSEcCtD
Amiodarone—Body temperature increased—Losartan—type 2 diabetes mellitus	4.72e-05	0.000281	CcSEcCtD
Amiodarone—Vomiting—Valsartan—type 2 diabetes mellitus	4.69e-05	0.00028	CcSEcCtD
Amiodarone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000279	CcSEcCtD
Amiodarone—Rash—Valsartan—type 2 diabetes mellitus	4.66e-05	0.000277	CcSEcCtD
Amiodarone—Dermatitis—Valsartan—type 2 diabetes mellitus	4.65e-05	0.000277	CcSEcCtD
Amiodarone—Vomiting—Orlistat—type 2 diabetes mellitus	4.64e-05	0.000276	CcSEcCtD
Amiodarone—Insomnia—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000276	CcSEcCtD
Amiodarone—Headache—Valsartan—type 2 diabetes mellitus	4.63e-05	0.000276	CcSEcCtD
Amiodarone—Diarrhoea—Metformin—type 2 diabetes mellitus	4.6e-05	0.000274	CcSEcCtD
Amiodarone—Rash—Orlistat—type 2 diabetes mellitus	4.6e-05	0.000274	CcSEcCtD
Amiodarone—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000274	CcSEcCtD
Amiodarone—Dermatitis—Orlistat—type 2 diabetes mellitus	4.6e-05	0.000274	CcSEcCtD
Amiodarone—Headache—Orlistat—type 2 diabetes mellitus	4.57e-05	0.000272	CcSEcCtD
Amiodarone—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000272	CcSEcCtD
Amiodarone—Asthenia—Irbesartan—type 2 diabetes mellitus	4.55e-05	0.000271	CcSEcCtD
Amiodarone—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000269	CcSEcCtD
Amiodarone—Pruritus—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000268	CcSEcCtD
Amiodarone—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000265	CcSEcCtD
Amiodarone—Dizziness—Metformin—type 2 diabetes mellitus	4.45e-05	0.000265	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000263	CcSEcCtD
Amiodarone—Fatigue—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000263	CcSEcCtD
Amiodarone—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.4e-05	0.000262	CcSEcCtD
Amiodarone—Nausea—Valsartan—type 2 diabetes mellitus	4.39e-05	0.000261	CcSEcCtD
Amiodarone—Constipation—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000261	CcSEcCtD
Amiodarone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.34e-05	0.000259	CcSEcCtD
Amiodarone—Nausea—Orlistat—type 2 diabetes mellitus	4.33e-05	0.000258	CcSEcCtD
Amiodarone—Asthenia—Losartan—type 2 diabetes mellitus	4.28e-05	0.000255	CcSEcCtD
Amiodarone—Vomiting—Metformin—type 2 diabetes mellitus	4.28e-05	0.000255	CcSEcCtD
Amiodarone—Rash—Metformin—type 2 diabetes mellitus	4.24e-05	0.000253	CcSEcCtD
Amiodarone—Dermatitis—Metformin—type 2 diabetes mellitus	4.24e-05	0.000252	CcSEcCtD
Amiodarone—Pruritus—Losartan—type 2 diabetes mellitus	4.22e-05	0.000252	CcSEcCtD
Amiodarone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000251	CcSEcCtD
Amiodarone—Headache—Metformin—type 2 diabetes mellitus	4.21e-05	0.000251	CcSEcCtD
Amiodarone—Dizziness—Irbesartan—type 2 diabetes mellitus	4.2e-05	0.00025	CcSEcCtD
Amiodarone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.19e-05	0.00025	CcSEcCtD
Amiodarone—Diarrhoea—Losartan—type 2 diabetes mellitus	4.09e-05	0.000244	CcSEcCtD
Amiodarone—Urticaria—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000242	CcSEcCtD
Amiodarone—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000241	CcSEcCtD
Amiodarone—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000241	CcSEcCtD
Amiodarone—Vomiting—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.00024	CcSEcCtD
Amiodarone—Rash—Irbesartan—type 2 diabetes mellitus	4e-05	0.000238	CcSEcCtD
Amiodarone—Dermatitis—Irbesartan—type 2 diabetes mellitus	4e-05	0.000238	CcSEcCtD
Amiodarone—Nausea—Metformin—type 2 diabetes mellitus	3.99e-05	0.000238	CcSEcCtD
Amiodarone—Headache—Irbesartan—type 2 diabetes mellitus	3.98e-05	0.000237	CcSEcCtD
Amiodarone—Dizziness—Losartan—type 2 diabetes mellitus	3.95e-05	0.000235	CcSEcCtD
Amiodarone—Vomiting—Losartan—type 2 diabetes mellitus	3.8e-05	0.000226	CcSEcCtD
Amiodarone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000225	CcSEcCtD
Amiodarone—Nausea—Irbesartan—type 2 diabetes mellitus	3.77e-05	0.000225	CcSEcCtD
Amiodarone—Rash—Losartan—type 2 diabetes mellitus	3.77e-05	0.000224	CcSEcCtD
Amiodarone—Dermatitis—Losartan—type 2 diabetes mellitus	3.76e-05	0.000224	CcSEcCtD
Amiodarone—Headache—Losartan—type 2 diabetes mellitus	3.74e-05	0.000223	CcSEcCtD
Amiodarone—Asthenia—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000219	CcSEcCtD
Amiodarone—Pruritus—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000216	CcSEcCtD
Amiodarone—Nausea—Losartan—type 2 diabetes mellitus	3.55e-05	0.000211	CcSEcCtD
Amiodarone—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000209	CcSEcCtD
Amiodarone—Dizziness—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000202	CcSEcCtD
Amiodarone—Vomiting—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000194	CcSEcCtD
Amiodarone—Rash—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000192	CcSEcCtD
Amiodarone—Dermatitis—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000192	CcSEcCtD
Amiodarone—Headache—Ramipril—type 2 diabetes mellitus	3.21e-05	0.000191	CcSEcCtD
Amiodarone—Nausea—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000181	CcSEcCtD
Amiodarone—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	2.63e-06	2.87e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	2.62e-06	2.87e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	2.58e-06	2.82e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.58e-06	2.82e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	2.58e-06	2.82e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	2.58e-06	2.82e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	2.57e-06	2.81e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.56e-06	2.8e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	2.54e-06	2.78e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.54e-06	2.78e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.54e-06	2.78e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.53e-06	2.76e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.52e-06	2.76e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.52e-06	2.76e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.52e-06	2.76e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	2.52e-06	2.75e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.51e-06	2.75e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	2.51e-06	2.74e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.51e-06	2.74e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	2.5e-06	2.73e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.5e-06	2.73e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.5e-06	2.73e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	2.49e-06	2.72e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.49e-06	2.72e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	2.48e-06	2.71e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.48e-06	2.71e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	2.47e-06	2.7e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.46e-06	2.69e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.46e-06	2.69e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	2.46e-06	2.69e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.45e-06	2.68e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	2.45e-06	2.67e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.42e-06	2.64e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.42e-06	2.64e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.41e-06	2.63e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.41e-06	2.63e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	2.4e-06	2.63e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.38e-06	2.6e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.37e-06	2.59e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.37e-06	2.59e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.37e-06	2.59e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	2.37e-06	2.59e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	2.36e-06	2.58e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	2.36e-06	2.58e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	2.35e-06	2.57e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.35e-06	2.57e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.34e-06	2.56e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	2.33e-06	2.54e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.32e-06	2.54e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.32e-06	2.54e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.32e-06	2.54e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.32e-06	2.54e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.32e-06	2.54e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.32e-06	2.53e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.31e-06	2.53e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.31e-06	2.52e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.3e-06	2.51e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.3e-06	2.51e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.3e-06	2.51e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.29e-06	2.5e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.29e-06	2.5e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.28e-06	2.49e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.28e-06	2.49e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.28e-06	2.49e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.28e-06	2.49e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.27e-06	2.49e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.27e-06	2.48e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.27e-06	2.48e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.26e-06	2.47e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.26e-06	2.47e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.26e-06	2.47e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.26e-06	2.47e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.25e-06	2.46e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.25e-06	2.46e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.24e-06	2.45e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.24e-06	2.45e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.21e-06	2.42e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.21e-06	2.42e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.2e-06	2.41e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.2e-06	2.4e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.19e-06	2.4e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.19e-06	2.39e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.18e-06	2.39e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.18e-06	2.39e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.17e-06	2.37e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.17e-06	2.37e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	2.16e-06	2.37e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.16e-06	2.36e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.16e-06	2.36e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.15e-06	2.35e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.13e-06	2.33e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.13e-06	2.33e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.13e-06	2.33e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.13e-06	2.33e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.13e-06	2.33e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.11e-06	2.31e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.1e-06	2.3e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.1e-06	2.29e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.07e-06	2.26e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.07e-06	2.26e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.06e-06	2.25e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.05e-06	2.24e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	2.05e-06	2.24e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.04e-06	2.23e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.03e-06	2.22e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.03e-06	2.22e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.03e-06	2.22e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.03e-06	2.22e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.02e-06	2.21e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	2.01e-06	2.2e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.01e-06	2.19e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.99e-06	2.18e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.99e-06	2.18e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.98e-06	2.17e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.98e-06	2.16e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.98e-06	2.16e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.97e-06	2.15e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.97e-06	2.15e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.97e-06	2.15e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.97e-06	2.15e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.96e-06	2.14e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.95e-06	2.13e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.94e-06	2.12e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.93e-06	2.11e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.93e-06	2.11e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.93e-06	2.11e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.93e-06	2.1e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.92e-06	2.1e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.92e-06	2.1e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.91e-06	2.09e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.9e-06	2.08e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.9e-06	2.08e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.89e-06	2.06e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.89e-06	2.06e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.88e-06	2.05e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.88e-06	2.05e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.88e-06	2.05e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.87e-06	2.04e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.87e-06	2.04e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.87e-06	2.04e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.86e-06	2.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.86e-06	2.03e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.85e-06	2.02e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.84e-06	2.01e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	1.84e-06	2.01e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.84e-06	2.01e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.84e-06	2.01e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.82e-06	1.99e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.82e-06	1.99e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.81e-06	1.98e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.8e-06	1.97e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.79e-06	1.96e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.79e-06	1.96e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.78e-06	1.94e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.77e-06	1.94e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.76e-06	1.93e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.76e-06	1.93e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.76e-06	1.93e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.76e-06	1.93e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.76e-06	1.92e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.76e-06	1.92e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.76e-06	1.92e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.75e-06	1.92e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.75e-06	1.91e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.75e-06	1.91e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.74e-06	1.9e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.71e-06	1.87e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.7e-06	1.86e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.69e-06	1.85e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.68e-06	1.84e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.68e-06	1.83e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.68e-06	1.83e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.65e-06	1.8e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.64e-06	1.79e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.63e-06	1.78e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.62e-06	1.77e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.62e-06	1.77e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.61e-06	1.76e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.61e-06	1.76e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.61e-06	1.76e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.58e-06	1.73e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.54e-06	1.69e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.53e-06	1.67e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.53e-06	1.67e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.52e-06	1.66e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.52e-06	1.66e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.51e-06	1.65e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.51e-06	1.65e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.51e-06	1.65e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.51e-06	1.65e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.5e-06	1.64e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.5e-06	1.64e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.5e-06	1.64e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.49e-06	1.63e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.48e-06	1.62e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-06	1.62e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.47e-06	1.61e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.47e-06	1.61e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.45e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.44e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.44e-06	1.58e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.41e-06	1.54e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.41e-06	1.54e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.41e-06	1.54e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.39e-06	1.52e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.38e-06	1.51e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.38e-06	1.5e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.35e-06	1.48e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.35e-06	1.47e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.33e-06	1.45e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.33e-06	1.45e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.32e-06	1.44e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.32e-06	1.44e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.32e-06	1.44e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.31e-06	1.43e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.31e-06	1.43e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.3e-06	1.42e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.29e-06	1.41e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.28e-06	1.4e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.24e-06	1.36e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.22e-06	1.33e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.21e-06	1.33e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.2e-06	1.32e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	1.3e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.18e-06	1.29e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.18e-06	1.28e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.16e-06	1.27e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.16e-06	1.27e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.15e-06	1.25e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.13e-06	1.23e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.12e-06	1.23e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.12e-06	1.23e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	1.19e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.04e-06	1.14e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.03e-06	1.12e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.01e-06	1.1e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.9e-07	1.08e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	9.07e-07	9.91e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.68e-07	9.48e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.68e-07	9.48e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	8.58e-07	9.38e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	8.11e-07	8.86e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.94e-07	8.67e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	7.43e-07	8.12e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	6.63e-07	7.25e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	6.47e-07	7.07e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	6.1e-07	6.67e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	6.05e-07	6.61e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.17e-07	5.65e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.99e-07	4.36e-06	CbGpPWpGaD
